Literature DB >> 15264183

Can young adult patients with proteinuric IgA nephropathy perform physical exercise?

Giorgio Fuiano1, Domenico Mancuso, Paola Cianfrone, Nicola Comi, Giuseppe Mazza, Francesco Marino, Laura Fuiano, Pasquale Zamboli, Alfredo Caglioti, Michele Andreucci.   

Abstract

BACKGROUND: It is not known whether physical exercise increases daily proteinuria in patients with proteinuric nephropathies, thus accelerating progression of the renal lesion. This study evaluates the acute effects of physical exercise on proteinuria in young adults with immunoglobulin A (IgA) nephropathy.
METHODS: Changes induced by intense physical exercise on quantitative and qualitative proteinuria were evaluated in basal conditions and after 10 days of ramipril therapy in 10 patients with IgA nephropathy, normal glomerular filtration rate (GFR), proteinuria between 0.8 and 1.49 g/24 h, and "glomerular" microhematuria before and after the end of a maximal treadmill Bruce test (B-test). The basal study also was performed in 10 age- and sex-matched healthy volunteers.
RESULTS: At rest, GFR averaged 141 +/- 23 mL/min; it increased by 16.3% +/- 3.3% (P < 0.005) and 7.1% +/- 1.6% at 60 and 120 minutes after the B-test, respectively. At rest, GFR-corrected proteinuria averaged protein of 0.76 +/- 0.21 mg/min/100 mL GFR; it increased to 1.55 +/- 0.28 mg/min/100 mL GFR after 60 minutes (P < 0.001) and declined to 0.60 +/- 0.11 mg/min/100 mL GFR at 120 minutes after the end of the B-test. The pattern of urinary proteins remained unchanged, as did microhematuria. Daily proteinuria was not different from the basal value on the day of the B-test. After ramipril therapy, patients showed a reduction in GFR, but no change in daily GFR-corrected proteinuria, pattern of urinary proteins, or hematuria.
CONCLUSION: The increase in proteinuria after exercise in our patients is significant and is not prevented by ramipril therapy, but lasts less than 120 minutes. Therefore, it cannot modify daily proteinuria. Thus, these data do not support the need to reduce acute physical activity in patients with nonnephrotic renal diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264183     DOI: 10.1053/j.ajkd.2004.04.030

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  The effectiveness and safety of modest exercise in Japanese patients with chronic kidney disease: a single-armed interventional study.

Authors:  Masami Hamada; Yoshinari Yasuda; Sawako Kato; Hiroki Arafuka; Motomitsu Goto; Mutsuharu Hayashi; Etsuko Kajita; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2015-07-25       Impact factor: 2.801

2.  Voluntary wheel running augments aortic l-arginine transport and endothelial function in rats with chronic kidney disease.

Authors:  Christopher R Martens; James M Kuczmarski; Jahyun Kim; John J Guers; M Brennan Harris; Shannon Lennon-Edwards; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

Review 3.  Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-A(y) mice.

Authors:  Yuji Ishikawa; Tomohito Gohda; Mitsuo Tanimoto; Keisuke Omote; Masako Furukawa; Saori Yamaguchi; Maki Murakoshi; Shinji Hagiwara; Satoshi Horikoshi; Kazuhiko Funabiki; Yasuhiko Tomino
Journal:  Exp Diabetes Res       Date:  2012-07-26

4.  Effects of exercise training on proteinuria in adult patients with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Lei Yang; Xiaoxia Wu; Ying Wang; Chunfeng Wang; Rong Hu; Yong Wu
Journal:  BMC Nephrol       Date:  2020-05-11       Impact factor: 2.388

5.  Practice pattern of physician's directions of exercise restriction in patients with chronic kidney disease: results from the Chronic Kidney Disease Japan Cohort study.

Authors:  Hiroki Nishiwaki; Takeshi Hasegawa; Megumi Shinji; Fujio Matsuo; Tsuyoshi Watanabe; Hirofumi Makino; Fumihiko Koiwa; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2018-03-19       Impact factor: 2.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.